Search Results - "Murrell, Dédée"

Phase 2B randomized study of nemolizumab in adults with moderate-to-severe atopic dermatitis and severe pruritus by Silverberg, Jonathan I., Pinter, Andreas, Pulka, Grazyna, Poulin, Yves, Bouaziz, Jean-David, Wollenberg, Andreas, Murrell, Dédée F., Alexis, Andrew, Lindsey, Lisa, Ahmad, Faiz, Piketty, Christophe, Clucas, Alan

“…Nemolizumab targets the IL-31 receptor α subunit involved in atopic dermatitis (AD) pathogenesis. We sought to evaluate a new dosing strategy of nemolizumab in…”
Get full text

A new dawn for orphan diseases in dermatology: The transformative potential of digital twins by Akbarialiabad, Hossein, Murrell, Dédée F.

Get full text

The future of digital pills and their potential use in dermatological clinical trials by Victory, Liana, Murrell, Dédée F.

Get full text

Dapsone for the management of severe epidermolysis bullosa simplex: A case report and evidence for a repurposing trial by Koszegi, Ben, Murrell, Dédée F.

Get full text

A Systematic Review of Drug-associated Bullous Pemphigoid by VERHEYDEN, Matthew J., BILGIC, Asli, MURRELL, Dédée F.

“…Bullous pemphigoid is an autoimmune subepithelial disease characterised by pruritus followed by urticarial plaques and finally bullae on the skin and mucosa…”
Get full text

Precision in treatment evaluation: importance of minimal clinically important differences (MCIDs) of outcome measures for autoimmune blistering diseases by Tseng, Henry, Stone, Corey, Murrell, Dédée F.

“…Autoimmune blistering diseases (AIBDs) comprise a group of rare conditions marked by autoantibodies that specifically target intercellular adhesion molecules…”
Get full text

A systematic review of randomized controlled trials for pemphigus vulgaris and pemphigus foliaceus by Martin, Linda K., MBBS, Werth, Victoria P., MD, Villaneuva, Elmer V., MD, Murrell, Dédée F., MA, BMBCh, MD, FACD

“…Background A range of interventions has been described for the treatment of pemphigus; however, the optimal therapeutic strategy has not been established…”
Get full text

Sustained clinical remission for 5 years in severe epidermolysis bullosa acquisita following rituximab infusions by Koszegi, Ben, Stone, Corey, Ishii, Norito, Hashimoto, Takashi, Murrell, Dédée F

Get full text

Dermatologic manifestations of hereditary hemochromatosis: A systematic review by Akbarialiabad, Hossein, Jamshidi, Parnian, Callen, Jeffrey P, Murrell, Dédée F

“…Hereditary hemochromatosis (HH) is a genetic disorder leading to excessive iron absorption, impacting multiple organs, notably the skin, nails and mucosae. The…”
Get full text

Interleukin‐17 inhibitors for the management of severe rosacea by Sarsam, Sera, Murrell, Dédée F.

Get full text

Establishing minimal clinically important differences for the Pemphigus Disease Area Index by Tseng, Henry, Stone, Corey, Shulruf, Boaz, Murrell, Dédée F

“…Pemphigus is a rare autoimmune blistering disease with potentially life-threatening consequences. Establishing minimal clinically important differences (MCIDs)…”
Get full text

Translation, cultural adaptation and validation of the German Quality of Life in Epidermolysis Bullosa (QOLEB) questionnaire by Salamon, Gudrun, Strobl, Sophie, Field-Werners, Ursula, Welponer, Tobias, Murrell, Dédée F, Diem, Anja

“…Epidermolysis bullosa (EB) is a rare disease characterised by skin fragility and a wide variety of symptoms. The Quality of Life in Epidermolysis Bullosa…”
Get full text

Psoriasis and osteoporosis: a literature review by Wi, Dohyen, Wilson, Anna, Satgé, Fanny, Murrell, Dédée F.

“…Psoriasis is a chronic inflammatory skin disease with complex comorbidities. Recent evidence has revealed how the inflammatory nature of psoriasis affects bone…”
Get full text

Efficacy and safety of Oleogel-S10 (birch triterpenes) for epidermolysis bullosa: results from the phase III randomized double-blind phase of the EASE study by Kern, Johannes S, Sprecher, Eli, Fernandez, Maria Florencia, Schauer, Franziska, Bodemer, Christine, Cunningham, Tracy, Löwe, Sandra, Davis, Charles, Sumeray, Mark, Bruckner, Anna L, Murrell, Dédée F

“…Epidermolysis bullosa (EB) is a heterogeneous group of rare, difficult-to-treat, inherited multisystem diseases affecting epithelial integrity. Patients with…”
Get full text

Conducting dermatology clinical trials during the COVID-19 pandemic by Sheriff, Tabrez, Dickenson-Panas, Helen, Murrell, Dédée F.

“…The clinical trials industry faces a number of challenges during the evolving coronavirus disease 2019 (COVID-19) pandemic, for example, site closures,…”
Get full text

Managing epidermolysis bullosa during the coronavirus pandemic: Experience and ideals by Ramirez-Quizon, Mae, Murrell, Dédée F.

“…The 2019 novel coronavirus pandemic has tremendously affected health-seeking behaviors. Fear of contracting the disease has been a major factor keeping…”
Get full text

Median canaliform nail dystrophy in a 2‐year‐old boy: Case report and review of the literature by Wilson, Anna, Tariq Khan, M., Murrell, Dédée F.

“…Median canaliform nail dystrophy (MCD) is a rare nail abnormality with an unknown etiology. We report the case of MCD of both great toenails in a 2‐year‐old…”
Get full text

Patients left behind: Rare dermatologic conditions miss the orphan drug development boom by Chavez, Afton, Licholai, Greg, Murrell, Dédée F.

Get full text

Inherited epidermolysis bullosa: New diagnostic criteria and classification by Intong, Lizbeth R.A., MD, Murrell, Dédée F., MA, BMBCh, MD

“…Abstract Epidermolysis bullosa (EB) is a group of inherited, mechanobullous disorders caused by mutations in various structural proteins in the skin. There…”
Get full text

Scoring Criteria for Autoimmune Bullous Diseases: Utility, Merits, and Demerits by Tseng, Henry, Stone, Corey, Murrell, Dédée F

“…Scoring systems play a crucial role in dermatology by providing objective measurements of disease severity, treatment efficacy, and outcome comparisons. In…”
Get full text